Tuberc Respir Dis > Volume 59(4); 2005 > Article
Tuberculosis and Respiratory Diseases 2005;59(4):413-417.
DOI: https://doi.org/10.4046/trd.2005.59.4.413    Published online October 1, 2005.
Insidious Onset of Amiodarone Pulmonary Toxicity Presented with Hemoptysis.
Hearn Kook Kim, Bock Hyun Jung, Kun Hee Han, Jung Won Hwang, Young Ju Cho, Yong Jin Park, Hyoung Jung Jung, Mi Hye Kim, Dae Sik Ryu, Gil Hyun Kang
1Department of Internal Medicine, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea. jbh@gnah.co.kr
2Department of Diagnostic Radiology, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea.
3Department of Diagnostic Pathology University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea.
Abstract
Amiodarone is widely used to control fatal arrhythmia. However, amiodarone therapy is associated with a relatively high incidence of pulmonary toxicity, up to 5 to 10%. Typical symptoms are nonspecific and often manifest as nonproductive cough, dyspnea and interstitial infiltrates in patients with acute pneumonitis or chronic fibrosis. However, hemoptysis is a very rare symptom of amiodarone pulmonary toxicity. We report a case of amiodarone pulmonary toxicity, who presented with hemoptysis and was successfully treated with the cessation of amiodarone, with review of the relevant literature.
Key Words: Amiodarone pulmonary toxicity, Hemoptysis, Acute pneumonitis


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next